The evidence-based treatment of AIDS-related non-Hodgkin’s lymphoma

This publication has 26 references indexed in Scilit:

• Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS
  The Lancet Oncology, 2003
• Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected Adults
  JNCI Journal of the National Cancer Institute, 2000
• Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy
  Blood, 2000
• Value of Long-Term Administration of Acyclovir and Similar Agents for Protecting Against AIDS-Related Lymphoma: Case-Control and Historical Cohort Studies
  Clinical Infectious Diseases, 2000
• B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS
  AIDS, 2000
• The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus?related systemic non-Hodgkin lymphoma
  Cancer, 1999
• Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.
  Journal of Clinical Oncology, 1998
• Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1997
• Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival
  Cancer, 1991
• AIDS-associated non-Hodgkin's lymphoma in San Francisco
  Published by American Medical Association (AMA) ,1989